Patent Classification

Treatment, Reproductive Related Disorders

1. Protection of the female reproductive system from natural and artificial insults
    
2. Tissue engineered female reproductive organs
    
3. Mutant glycoproteins
    
4. WNT signalling in reproductive organs
    
5. Inactivated respiratory syncytial viral vaccines
   
   
6. Screening test for the lethal genetic trait of recurrent spontaneous pregnancy loss
    
   
7. Methods for treating male erectile dysfunction

Treatment, Restless Leg Syndrome

1. Methods and compositions for administration of iron for the treatment of restless leg syndrome
    
2. Ketamine treatment of restless legs syndrome
    
3. Use of valeriana for the treatment of restless leg syndrome and related disorders

Treatment, Rheumatoid Arthritis

1. Diclofenac sodium oral pharmaceutical
    
2. Method for treating autoimmune and alloimmune diseases
    
3. Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics
    
4. Sphingomyelin enhancement of tumor therapy
    
5. Treatment for joint inflammation
    
6. Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes
   
   
7. Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease

Treatment, Rhinitis/Sinusitis

1. Fluticasone propionate nasal pharmaceutical formulations and methods of using same
    
2. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
    
3. Nasal passage cleaning composition
    
4. Composition for cleansing the sinuses
    
5. Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
    
6. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
    
7. Single-dose antihistamine/decongestant formulations for treating rhinitis

Treatment, Ribozyme Related Therapy

1. Ribozyme therapy for the treatment of proliferative skin and eye diseases

Treatment, Rubella

1. Highly infectious rubella virus DNA constructs and methods of production
    
2. Specificity in the detection of anti-rubella IGM antibodies
    
3. Specificity in the detection of anti-rubella IgM antibodies

Treatment, Sebaceous Gland Disorders

1. Method for treating a cholinergic influenced sweat gland
    
2. Compositions and methods for decreasing sebum production

Treatment, Sepsis/Septic Shock

1. Treatment of sepsis with 5-ethyl-1-phenyl-2(1H)-pyridone
    
2. Methods of identifying individuals at reduced risk of sepsis
    
3. Induction of antibiotic proteins and peptides by LAIT/sCD14-protein
    
4. Method for diagnosis of sepsis by determination of S100B
    
5. Early detection of sepsis
    
6. Compositions and methods for the diagnosis and treatment of sepsis
    
7. Methods of treatment for septic shock with urine extract
    
8. Protein C or activated protein C-like molecules
    
9. Antagonists of HMG1 for treating inflammatory conditions
    
10. Antagonists of HMG1 for treating inflammatory conditions
     
11. Anti-sepsis conjugate vaccine
     
12. Compositions and methods for the treatment of sepsis
     
13. Animal models and methods for sepsis
     
14. Therapeutic agent for the treatment of septicaemia its preparation and use
     
15. Immunoadsorber for use in sepsis therapy
     
16. Compositions and methods for the treatment of sepsis
     
17. Treatment of sepsis with TAFI
     
18. Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
     
19. Method for removing pyrogens from plasma and blood for treatment of septic shock
     
20. Compositions and methods for the treatment of sepsis
     
21. Method of treating systemic inflammatory response syndrome
     
22. Immunological activity for a peptide of the limulus anti-LPS factor
     
23. Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
     
24. Method of treating sepsis and ARDS with chemokine .beta.-4
    
    
25. Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
    
    
26. Enhanced circulation effector composition and method
     
    
27. Methods and compositions for ameliorating the symptoms of sepsis
     
28. Methods for prevention and treatment of septic shock

Treatment, Sexually Transmitted Diseases/Syphilis

1. .beta.-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
    
2. Method for detecting syphilis using synthetic antigens
    
3. Human papilloma virus treatment
    
4. Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
    
5. Methods of treating human females susceptible to HSV infection
    
6. Methods for isolating T. pallidum rare outer membrane proteins
    
7. Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
    
8. Vaginal lactobacillus medicant
    
9. Composition and method for prevention of sexually transmitted diseases, including aids
    
   
10. Method for preventing sexually transmitted diseases
     
    
11. Topical application of antibodies for prophylaxis against sexually transmitted diseases and pregnancy

Treatment, Shock, Cardiovascular/Physiological

1. Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
    
2. Method for regulation of microvascular tone
    
3. Treatment of shock using adrenomedullin binding protein-1
    
4. Method for treatment and prevention of physiological shock

Treatment, Sickle Cell Disease

1. Gene regulation therapy involving ferritin
    
2. Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
    
3. Method of treating sickle cell disease or thalassemia

Treatment, Silicon Deficiency

1. Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex 

Treatment, Skin/Nail Related Disorders/Cancer

1. .alpha.-MSH-antagonist dipeptide conjugates
    
2. Urea compounds that promote desquamation
    
3. Plant extracts for treating skin disorders and enhancing healing of wounds for diabetic patients
    
4. Compositions and methods for targeting cancer-specific transcription complexes
    
5. Method of treating skin ulcers with vectors encoding hepatocyte growth factor
    
6. Method for protecting humans against superficial vasodilator flush syndrome
    
7. Method of treating a mucosal and/or dermal associated condition
    
8. Peptides for stimulating an immune response against melanoma
    
9. Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
    
10. Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
     
11. Tissue treatments with adipocyte cells
     
12. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
     
13. Method for constructing reconstructed skin
     
14. Triple anti-irritant composition
     
15. Retinoid solutions and formulations made therefrom
     
16. Methods of treating dermal ulcers using glucans
     
17. Method of production of artificial skin
     
18. Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
     
19. Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
     
20. Methods of treating cutaneous ulcers and grafts using IL-23
     
21. Monoclonal antibodies to human high molecular weight-melanoma associated antigen
     
22. Method and composition for treating skin wounds with epidermal growth factor
     
23. Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
     
24. si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
     
25. Identification of a novel BHD gene
     
26. Melanoma therapy
     
27. Modulation of insulin like growth factor I receptor expression
     
28. Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
     
29. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
     
30. Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
     
31. Method of treating granuloma annulare or sarcoid
     
32. Microparticle-based diagnostic methods
     
33. Topical composition comprising feverfew
     
34. Use of placental alkaline phosphatase to promote skin cell proliferation
     
35. Skin treatment for relief of itch
     
36. Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
     
37. Topical acne vulgaris medication with a sunscreen
     
38. Benzoyl peroxide compositions having increased potency
     
39. Methods of increasing the efficacy of peroxides
     
40. Nucleic acid underexpressed in melanoma
     
41. Treatment of holocrine gland dysfunction with clostridia neurotoxins
     
42. Treatment of melanoma by reduction in clusterin levels
     
43. Use of nitroxides in treating skin disease
     
44. Pharmaceutical composition comprising dimethylsulfoxide and ozone
     
45. Topical composition and method for the treatment and prophylaxis of dermal irritations
     
46. Method of treating skin wounds with vectors encoding hepatocyte growth factor
     
47. Artificial dermis and production method therefor
     
48. Compositions and methods for enhancing corticosteroid delivery
     
49. Treatment of ungual and subungual diseases
     
50. Drug therapy for celiac sprue
     
51. Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities
     
52. Use of prenylated flavones
     
53. Bandage composition containing phage associated lytic enzymes useful for treating dermatological infections
     
54. Emulsion containing ascorbic acid and its uses in the cosmetics and dermatological fields
     
55. Methods for treatment of cutaneous T-cell lymphoma
     
56. Recombinant oncolytic adenovirus for human melanoma
     
57. Stable water in oil aminophylline emulsions
     
58. Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil
     
59. Pharmaceutical compositions and methods for managing skin conditions
     
60. Melanoma vaccine and methods of making and using same
     
61. Composition and method for treatment and prevention of pruritis
     
62. Compositions for the treatment of pigmentation disorders and methods for their manufacture
     
63. Method for examining the involvement of opioid peptides in prurtis
     
64. Oral composition and method for the treatment of inflammatory cutaneous disorders
     
65. Methods for inhibiting cutaneous inflammation and hyperpigmentation
     
66. Use of a polypeptide for treatment of pruritus in animals
     
67. Process and composition for enhancing the action of vitamin a on the cellular activity of an individual, and use of vitamin c
     
68. Stable hydrogen peroxide compositions, products and methods of use
     
69. Antioxidants in clusters of structured water
     
70. Skin penetration enhancing components
     
71. Laminin chains: diagnostic uses
     
72. Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
     
73. MHC-class II restricted melanoma antigens and their use in therapeutic methods
     
74. Skin and mucosal treatment formulation
     
75. Epidermal melanocyte culture formulations
     
76. Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses
     
77. Use of a polypeptide for treatment of pruritis in animals
     
78. Melanoma therapy
     
79. Stabilized silver-ion amine complex compositions and methods
     
80. Antibodies against the MUC18 antigen
     
81. Cultured skin and method of manufacturing the same
     
82. Topical medicament for treating nappy rash
     
83. Animal model system for photodamage, photoaging and skin wounding
     
84. Use of KPV tripeptide for dermatological disorders
     
85. Method for treating skin disorders
     
86. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
     
87. Dermatomycosis vaccine
     
88. Compositions and methods for high sorption of skin materials and delivery of sulfur
     
89. Genetically modified fibroblast cells
     
90. Gentle-acting skin disinfectants
     
91. Method of treating pruritis and composition thereof
     
92. Topical administration of pharmacologically active bases in the treatment of warts
     
93. Composition and method for treating diaper rashes and skin irritations caused by acidic secretions
     
94. Hyaluronic Acid in soft gel form
     
95. Multi-purpose skin balm including skin balm for psoriasis
     
96. Ribozyme therapy for the treatment of proliferative skin and eye diseases
     
97. Method of using hydroxycarboxylic acids or related compounds for treating skin changes associated with intrinsic and extrinsic aging
     
98. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
     
99. Compositions and methods for enhancing corticosteroid delivery
     
100. System and method for evaluating agents which prevent oxidative damage
      
101. Preparation for the treatment of pigmentation disorders
      
102. Bandage composition containing a phage associated lytic enzyme
      
103. Methods of increasing the efficacy of peroxides
      
104. Keratinocyte cultures and uses thereof
      
105. Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
      
106. DNA repair polypeptides and methods of use
      
107. Method for detection of biological factors in epidermis
      
108. Vaccine adjuvants for immunotherapy of melanoma
      
109. Method of treating palmar and plantar fibromatosis
      
110. Conjugate for treating inflammatory infectious and/or skin diseases
      
111. Transgenic mouse model of basal cell carcinoma
      
112. Anti-irritating rosacea treatment
      
113. Chinese herbal composition for treating eczema and psoriasis
      
114. Methods for treatment of inflammatory diseases
      
115. Curcumin and curcuminoid inhibition of angiogenesis
      
116. Allergic contact dermatitis treatment and composition therefor
      
117. Reparatives for chemosurgery and laser (thermal) therapy
      
118. Epidermis/dermis equivalents and aged skin equivalents shaped therefrom
      
119. Method for delivering ascorbic acid and acetone to the dermal layer of the skin
      
120. Topical capsaicin preparation
      
121. Method for combating summer eczema and malanders
      
122. Keratinocyte derived protease
      
123. Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
      
124. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
      
125. Collagen production promoter composition
      
126. Methods for treatment of inflammatory diseases
      
127. Use of nuclease to reduce wrinkles and discolorations in humans
      
128. Method for inhibition of photocarcinogenesis or photoimmunosuppression using niacin
      
129. Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
      
130. Creams containing vitamin D3 derivatives
      
131. Methods and compositions for the protection of mitochondria
      
132. Method for inhibiting skin lesion formation using histamine as the active ingredient
      
133. Antioxidants in clusters of structured water
      
134. Use of bacterial phage associated lysing enzymes for treating dermatological infections
      
135. Bioactive glass treatment of inflammation in skin conditions
      
136. Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
     
     
137. Method for diminishing wrinkles and fine lines of the skin by the topical application of .DELTA.5-androstene-3.beta.-ol-7, 17 dione and metabolizable precursors thereof
     
     
138. Chinese herbs extract
     
     
139. Use of plant extracts for treatment of acne and furuncle
     
     
140. Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis
     
     
141. Methods of hydrating mammalian skin comprising oral administration of a defined composition
     
     
142. Method of promoting skin cell metabolism
     
     
143. Composition and method for topically treating Peyronie's Disease, Dupuytren's hand contracture, Ledderhose Fibrosis, erectile dysfunction arising from plaque accumulations, and scarring
     
     
144. Physiological combination of active substances to enhance the skin's defenses against noxious agents
     
     
145. Method and composition for the treatment of scars
      
     
146. Anti-inflammatory compositions comprising peptide derivatives of .alpha.-MSH/algal extracts
      
     
147. Reparatives for ultraviolet radiation skin damage
      
     
148. Methods for the treatment of immunologically-mediated skin disorders
      
     
149. Composition and method for control and treatment of cutaneous inflammation
      
     
150. Protease inhibitors for use in the treatment of psoriasis
      
     
151. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
      
     
152. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
      
     
153. Nutraceutical composition for protection against solar radiation
      
     
154. Antimutagenic compositions for treatment and prevention of photodamage to skin
      
     
155. Method for treating pre-malignant basal and squamous cell lesions of the epithelium
      
     
156. Method of treating skin disorders with high-strength retinoids
      
     
157. Treatment of skin damage using polyenylphosphatidylcholine
      
     
158. Targeting of sebaceous follicles as a treatment of sebaceous gland disorders

Treatment, Sleep Disorders/Circadian Rhythms

1. Compositions and methods for sleep regulation
    
2. Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
    
3. Buccal, polar and non-polar spray containing zolpidem
    
4. Methods and compositions for nasal administration of modafinil
    
5. Compositions and methods for the induction and maintenance of quality sleep
    
6. Methods for identifying compounds that modulate vigilance states
    
7. Melatonin-based composition for improved sleep
    
8. Screening assay to identify modulators of the sleep/wake cycle
    
9. Administration of hypocretin-1 for treatment of narcolepsy
    
10. Autonomic nerve regulating agent
     
11. Sleep inducing toothpaste made with natural herbs and a natural hormone
     
12. Screening and therapeutic methods for promoting wakefulness and sleep
     
13. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
     
14. Method of treating sleeplessness with melatonin on an acute basis
     
15. Methods and compositions for improving sleep
     
16. Neuropharmacological treatments of sleep-related breathing disorders
     
17. Tryptophan source from plants and uses therefor
     
18. Administering bacteria to improve sleep
     
19. Mediation of circadian rhythms
    
    
20. Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
    
    
21. Use of serotonin agonists to alleviate disordered breathing episodes in a mammal
    
    
22. Method for treating or preventing sleep disorders
    
    
23. Pharmacological treatment for sleep apnea
     
    
24. Sleep quality improvement using a growth hormone secretagogue

Treatment, Smallpox

1. Methods and compositions for the identification of anti-poxvirus agents
    
2. Smallpox vaccine
    
3. Oral vaccinia formulation
    
4. Smallpox vaccine
    
5. DNA vaccines against poxviruses

Treatment, Smoking Cessation

1. Methods of reducing the nicotine content of tobacco plants and tobacco plants obtained thereby
    
2. Method and apparatus for reducing the incidence of tobacco use
    
3. Beverage treated with nicotine
    
4. Nicotine replacement applique
    
5. Treating the effect of nicotine
    
6. Chewing gum composition for effectively eliminating nicotine accumulated in a human body
    
7. Therapeutic and diagnostic methods dependent on CYP2A enzymes
    
8. Two-stage transmucosal medicine delivery system for symptom relief
    
9. Nicotine-containing, controlled release composition and method
    
10. Composition and method for smoke detoxification
     
11. Compositions and methods for the control of smoking
     
12. Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption
     
13. Method for reducing or eliminating smoking
     
14. Nicotine mucosal spray
     
15. Pharmaceutical composition containing two active ingredients for smoking cessation
     
16. Edible herbal compositions for relieving nicotine craving
     
17. Inhibition of psychostimulant-induced and nicotine-induced craving
     
18. Herbal composition as a substitute for tobacco
     
19. Tobacco cembranoids block the expression of the behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptors
     
20. Nicotine delivery compositions
     
21. Methods and compositions for treating chronic disorders using optically pure (+)-bupropion
     
22. Plantago majorand piper methysticum compound for use in treating a tobacco or nicotine habit
     
    
23. Compositions and methods for the control of smoking
     
    
24. Nicotine lozenge
     
    
25. Nicotine beverage
     
    
26. Intestinal absorption of nicotine to treat nicotine responsive conditions
     
    
27. Methods to abate the use of tobacco by humans
     
    
28. Solution containing nicotine

Treatment, Snake/Insect Bite

1. Antivenom immunesera

Treatment, Snoring

1. Therapeutic agent for the suppression of snoring noises

Treatment, Spinal Cord/Brain Injury

1. Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus
    
2. Treatment of brain damage
    
3. Treatment of and/or prophylaxis against brain and spinal cord injury
    
4. Mechanically elongated neuronal cells

Treatment, Spinal Muscular Atrophy

1. Treatments for spinal muscular atrophy

Treatment, Streptococcus/Staphylcoccus Related Diseases

1. Molecular identification of Staphylococcus-genus bacteria
    
2. Use of RIP in treating staphylococcus aureus infections
    
3. Method of protecting against staphylococcal infection
    
4. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
    
5. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
    
6. Methods and compositions for the treatment and prevention of staphylococcal infections
    
7. Staphylococcus antibodies
    
8. Streptococcus uberis adhesion molecule
    
9. Protein-based Streptococcus pneumoniae vaccines
    
10. Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
     
11. Vaccine against streptococci
     
12. Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
     
13. Peptide vaccines against group A streptococci
     
14. Vaccine against staphylococcus intoxication
     
15. Compositions and methods for affecting virulence determinants in bacteria
     
16. Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
     
17. Multivalent streptococcal vaccine compositions and methods for use
     
18. Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection
     
19. Streptococcal C5a peptidase vaccine
     
20. Collagen-binding proteins from Streptococcus pyogenes
     
21. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
22. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
23. Streptococcus pneumoniae proteins and vaccines
     
24. Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
     
25. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
     
26. Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
     
27. Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
     
28. Kits for use in detecting resistance to streptogramin A and related compounds
     
29. Nasal spray for treating streptococcal infections
     
30. Use of hop acids to inhibit growth of Staphylococcus aureus and prevent toxic shock syndrome
     
31. Virulence genes, proteins, and their use
     
32. Multiple antigenic peptides immunogenic against Streptococcus pneumonia
     
33. Streptococcus pneumoniae proteins and vaccines
     
34. Treatment of E. faecium infection
     
35. Ophthalmic ointments for treating infective eye disease
     
36. Pneumococcal protein homologs and fragments for vaccines
     
37. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
     
38. Collagen-binding proteins from streptococcus pyogenes
     
39. Group A streptococcal vaccines
     
40. Bacterial superantigen vaccines
     
41. Staphylococcal immunotherapeutics via donor selection and donor stimulation
     
42. Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections
     
43. Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action
     
44. Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein
     
45. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
     
46. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
     
47. IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein
     
48. Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
     
49. Streptococcus iniae vaccine

Treatment, Stroke

1. Method for prophylaxis of reflex sympathetic dystrophy after stroke
    
2. Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
    
3. Composition and method for preventing recurrence of stroke
    
4. HDL for the treatment of stroke and other ischemic conditions
    
5. Mutation associated with strokes
    
6. Prevention of brain damage in stroke
    
7. Diagnostic assay for stroke
    
8. Method of improving ischemic muscle function by administering placental growth factor
    
9. Method for predicting cardiovascular events
    
10. Genes involved in stroke response and/or regulated by FK506, proteins encoded thereby, and methods of use
     
11. Composition and treatment method for brain and spinal cord injuries
     
12. Method of diagnosing ischemic stroke via UCP-2 detection
     
13. Polydithicarbamate-containing non-targeting marcomolecules and the use thereof for therapeutic and diagnostic applications
     
14. Method of treating cytotoxic damage
     
15. Treatment of cerebral disorders by inhibition of IL-8 binding to receptor
     
16. Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
     
17. Methods for treating vascular disorders
     
18. Method for aiding cerebral recovery following neurodegeneration
     
19. Method for improving disturbances of activities of daily living after stroke

Treatment, Sudden Infant Death Syndrome

1. Use of ammonium compounds and/or urea

Treatment, Surgery, Bypass/Heart

1. Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
    
2. Organ arrest, protection and preservation
    
3. Postsurgical treatment with dichloroacetate
    
4. Pharmacologic drug combination in vagal-induced asystole

Treatment, Surgery, General

1. Degradation-resistant fibrinogen sealants
    
2. Resorbable thin membranes
    
3. Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions
    
4. Method for preventing the formation of adhesions following surgery or injury
    
5. Medical adhesives for surgery
    
6. Method of treating post-surgical acute pain
    
7. Protein crosslinkers, crosslinking methods and applications thereof
    
8. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
    
9. Dressing for treatment of short wounds located in high tension areas
    
10. Carrier with solid fibrinogen and solid thrombin
     
11. Dilution resistant viscoelastic compositions
     
12. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
     
13. Tissue glue with improved antiadhesive properties
     
14. Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist
     
15. Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
     
16. Methods for forming regional tissue adherent barriers and drug delivery systems
     
17. Suturable adhesion-preventing membrane
     
18. Salt solution for colon cleansing
     
19. Method for preparing a calcium phosphate pasty material for injection
     
20. Light energized tissue adhesive
     
21. Modifying tissue surfaces by liquid crystal formation
     
22. Light energized tissue adhesive conformal patch

Treatment, Symptomatic Treatment

1. Methods for treating disease states comprising administration of low levels of antibodies

Treatment, Systemic Lupus Erythematosus

1. Method for treatment of SLE